Type 2 Diabetes: Empowering Patients with Personalized Treatment, ATTD 2025 Conference Catch-Up
Description
In this episode of ATTD 2025 Conference Catch-Up, we dive into Type 2 Diabetes: Empowering Patients with Personalized Treatment, featuring cutting-edge discussions on the role of SGLT2 inhibitors, CGM, and personalized approaches to managing type 2 diabetes and pre-diabetes, with a focus on improving patient outcomes.
Join us as we summarize key takeaways from these thought-provoking presentations:
- SGLT2i Use in Young People Following Approval by FDA and EMA in Type 2 Diabetes – Dr. Lori Laffel
- Do Different Types of Prediabetes Require Different Types of Prevention Approaches? – Dr. Viswanathan Mohan
- Use of CGM in Pre-Type 2 Diabetes – Prof. Viral Shah
This episode is an essential listen for endocrinologists, diabetes care specialists, healthcare providers, and researchers focusing on innovative, patient-centered approaches to managing type 2 diabetes and pre-diabetes, aimed at improving both clinical outcomes and patient experiences.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
United States
